Helixgate https://validator.w3.org/feed/docs/rss2.html Scribing startup Abridge adds NEJM, JAMA as it moves into medical AI search Pregnancy Sickness Study Identifies New Genetic Links FDA weighs support for compounding popular peptides Biotech stocks are on a tear again STAT+: CMS proposes rolling back breakthrough device payment flexibilities Fujifilm Biotechnologies Opens New QC Lab in Denmark Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers Digital Twin Process Could Slash Microbial Protein Costs In vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic Biogen filing reveals Apellis deal details; Telix raises $600M Novel Targets for Complex Cancer Revealed by Genetic Regulatory Node Mapping Tampa General’s AI journey Research collaboration to ‘strengthen pandemic preparedness’  Revolution Medicines prices $2B raise as XBI reaches heights not seen since pandemic Astellas’ consolidation efforts to impact 50 Universal Cells employees STAT+: Novartis CEO joins Anthropic’s board Whitepaper: CDMOs at a Crossroads China dominates big licensing deals as M&A starts 2026 with a bang Trump DOJ report says Biden administration treated anti-abortion protestors unfairly Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico Lilly’s new obesity pill linked to ‘serious’ safety signals, FDA requests more data Terremoto raises $108M to make an ‘earthquake’ in small molecule space STAT+: New Bain biotech startup, building on BMS drugs, gets a name and a CEO J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen Opinion: Hosting the ‘intellectual wrestling match’ between MAHA, public health Could biotech layoffs push life sciences talent to go global? 5 biopharma M&A deals where the workforce was the prize Deep dive: Checking in with the FDA An inducible base editing platform for cancer functional genomics in vivo Engineered Miniature CRISPR Boosts Gene‑Editing Efficiency in Human Cells CAR T Cell Therapy Biomanufactured by Cellares Infused Into First Two Patients Regeneron, Telix Launch Up-to-$4.3B Cancer-Focused Radiopharma Drug, Diagnostic Collaboration FDA bolsters bespoke therapy framework with new draft safety guidelines FDA asks for more data on Lilly’s Foundayo to assess heart, liver risks Replimune looks ahead as repeat CRL speeds the company’s decline STAT+: Congress returns to a packed health care agenda Laigo Bio announces new CSO as part of board appointments  Travere wins long-awaited approval for kidney disease drug 50 employees impacted as Astellas closes Universal Cells’ Seattle office Revolution Medicines leads latest wave of stock offerings, totaling $1.5B AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development Home Bonus: Q1 2026 Job Market Update Scientific Advisory Board STAT+: FDA pressures drugmakers to report trial results From Colossal to Chickens: The Scientists Behind Neion Bio’s Biologics Platform Lilly investing billions to prepare for overseas oral GLP-1 launches Lilly wants to bridge cancer care gap with $300M ADC biotech buy STAT+: Hospitals offer chatbots to fight off ChatGPT